Paradigm Biocapital Advisors LP Scholar Rock Holding Corp Transaction History
Paradigm Biocapital Advisors LP
- $2.62 Billion
- Q4 2024
A detailed history of Paradigm Biocapital Advisors LP transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 400,000 shares of SRRK stock, worth $14.7 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
400,000Holding current value
$14.7 Million% of portfolio
0.66%Shares
1 transactions
Others Institutions Holding SRRK
# of Institutions
257Shares Held
88.6MCall Options Held
1.82MPut Options Held
1.17M-
Price T Rowe Associates Inc Baltimore, MD9.28MShares$342 Million0.05% of portfolio
-
Siren, L.L.C. New York, NY9.25MShares$341 Million17.66% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$209 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA5.61MShares$207 Million74.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$175 Million0.0% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $1.9B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...